Literature DB >> 6259593

[Kinetics of cefotaxime in healthy subjects (author's transl)].

J F Acar, J Guibert, M D Kitzis.   

Abstract

Serum and urinary levels of cefotaxime after either intramuscular (i.m.) or intravenous (i.v.) administration were determined in 6 normal human subjects. By the i.m. route the serum half-life was 80 minutes. The peak serum concentration, at 30 minutes, reached 12 and 24 mcg/ml after injection of 500 mg and 1 g. Concentrations in the urine were 500 mcg/ml within 6 hours after an injection of 500 mg; they reached 1000 mcg/ml after an injection of 1 g. Urinary elimination amounted to 50% during the first 6 hours; it reached 60% during 24 hours. By the i.v. route, the serum half-life was 40 minutes. The concentration in the serum was more than 100 mcg/ml at the fifth minute after an injection of 1 g. Concentrations in the urine were 1300 mcg/ml within 4 hours after injection of cefotaxime. The urinary elimination amounted to 60--64% during 12 hours. Intravenous infusion of 1 g during 4 hours gave a serum level, from the second hour, approaching 15 mcg/ml. The concentration in the urine was 600 mcg/ml within 4 hours. The urinary elimination amounted to 50% in 12 hours. Protein binding of cefotaxime ranged from 36 to 38%.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259593

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  4 in total

1.  Pharmacokinetics of cefpimizole in normal humans after single- and multiple-dose intravenous infusions.

Authors:  D B Lakings; J M Friis; R J Brown; H R Allen
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

2.  Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.

Authors:  D B Lakings; E Novak; J M Friis; C M Lunan; L M Paxton
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 4.  Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.